BPC-157 may be one of the most talked-about peptides in the recovery and biohacking world, but the legal landscape around it is anything but straightforward
More specifically, research shows small peptides under 16 kilodaltons (kDa) primarily leave the injection site through diffusion into blood capillaries, while larger proteins are predominantly absorbed via the lymphatic system
Concerning BPC-157, for example, six committee members voted against its inclusion on the Bulks List, and one abstained
Some people report redness or itching where they get their injections
After preparation: Store prepared solutions at 28 C where compatible with your SOP, protect from light, and avoid repeated temperature cycling
Research in rodent models suggests BPC-157 can both protect against and counteract NO pathway dysregulation exerting what the literature describes as a stabilising effect on NO signalling rather than simply upregulating or downregulating it